Brain SPECT and vascular cognitive impairments

被引:0
|
作者
Farid, K. [1 ,2 ]
Ducasse, V. [3 ]
Meyer, L. [3 ]
Chokron, S. [4 ]
Peroz, J. [3 ]
Lieber, A. [3 ]
Helft, G. [5 ]
Blacher, J. [2 ,3 ]
Caillat-Vigneron, N. [1 ]
机构
[1] CHU Hotel Dieu, Nucl Med Serv, F-75181 Paris 04, France
[2] Univ Paris 13, CRNH IDF, CNAM, UMR Inserm U557,Inra U1125, F-93017 Bobigny, France
[3] CHU Hotel Dieu, Ctr Diagnost & Therapeut, F-75181 Paris 04, France
[4] CNRS, UMR 5105, Serv Neurol, Unite Fonct Vis & Neurocognit, F-75940 Paris 19, France
[5] Hop La Pitie Salpetriere, Inst Cardiol, F-75651 Paris 13, France
来源
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 07期
关键词
Perfusion brain SPECT; Cardiovascular risk factor; Vascular dementia; Dysexecutive syndrome; WHITE-MATTER HYPERINTENSITIES; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; CEREBROVASCULAR-DISEASE; INCIDENT DEMENTIA; RISK-FACTORS; DOUBLE-BLIND; PREVENTION; ASPIRIN; MICROANGIOPATHY;
D O I
10.1016/j.mednuc.2010.05.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The vascular cognitive impairment (VCI) is a heterogeneous group of various etiologies, which share a presumed vascular cause. Although the age is the most important risk factor, the cardiovascular risk factors are also involved. A relatively high proportion of these cognitive disorders could be prevented or delayed. Only the treatment of arterial hypertension is recognized as a factor in preventing vascular dementia. MRI is the examination of choice for the investigation of cerebral vascular pathology. However, this morphological imaging is insufficient and does not provide useful functional information. Perfusion brain SPECT is not widely used in the exploration of VCI. Strategies for screening VCI are not standardized and long-term studies are needed to establish the better prevention of cognitive vascular disorders. This article aims to summarize the possible benefit of cerebral perfusion SPECT in the exploration of VCI. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 50 条
  • [1] Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairment
    Farid, Karim
    Petras, Slavomir
    Ducasse, Valerie
    Chokron, Sylvie
    Helft, Gerard
    Blacher, Jacques
    Caillat-Vigneron, Nadine
    NUCLEAR MEDICINE COMMUNICATIONS, 2012, 33 (06) : 571 - 580
  • [2] NEUROIMAGING OF COGNITIVE IMPAIRMENTS IN VASCULAR DISEASE
    Di Perri, Carol
    Dalaker, Turi O.
    Beyer, Mona K.
    Zivadinov, Robert
    NEUROBIOLOGY OF DEMENTIA, 2009, 84 : 49 - +
  • [3] Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health
    Kalaria, Raj N.
    Akinyemi, Rufus O.
    Paddick, Stella-Maria
    Ihara, Masafumi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (01) : 25 - 44
  • [4] Vascular Cognitive Disorder
    Paradise, Matt B.
    Sachdev, Perminder S.
    SEMINARS IN NEUROLOGY, 2019, 39 (02) : 241 - 250
  • [5] Pharmacotherapy for Vascular Cognitive Impairment
    Farooq, Muhammad U.
    Min, Jiangyong
    Goshgarian, Christopher
    Gorelick, Philip B.
    CNS DRUGS, 2017, 31 (09) : 759 - 776
  • [6] Subcortical Vascular Cognitive Impairment, No Dementia: EEG Global Power Independently Predicts Vascular Impairment and Brain Symmetry Index Reflects Severity of Cognitive Decline
    Sheorajpanday, Rishi V. A.
    Marien, Peter
    Nagels, Guy
    Weeren, Arie J. T. M.
    Saerens, Jos
    van Putten, Michel J. A. M.
    De Deyn, Peter P.
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2014, 31 (05) : 422 - 428
  • [7] Stroke injury, cognitive impairment and vascular dementia
    Kalaria, Raj N.
    Akinyemi, Rufus
    Ihara, Masafumi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (05): : 915 - 925
  • [8] Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications
    Rojas-Fernandez, Carlos H.
    Moorhouse, Paige
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1310 - 1323
  • [9] Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications
    Levine, Deborah A.
    Langa, Kenneth M.
    NEUROTHERAPEUTICS, 2011, 8 (03) : 361 - 373
  • [10] Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis
    Battle, Ceri E.
    Abdul-Rahim, Azmil H.
    Shenkin, Susan D.
    Hewitt, Jonathan
    Quinn, Terry J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):